Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus.
about
Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patientsEndothelial microparticles: sophisticated vesicles modulating vascular function.Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.No Significant Reduction of Circulating Endothelial-Derived and Platelet-Derived Microparticles in Patients with Psoriasis Successfully Treated with Anti-IL12/23Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.Pathogenic roles of microvesicles in diabetic retinopathy.Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults.Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes.β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.Applicability of extracellular vesicles in clinical studies.The signature of circulating microparticles in heart failure patients with metabolic syndrome.Highlights - June 2017.Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin
P2860
Q33800362-FD74195F-7DDA-4815-8D1E-D61361D9B51EQ35624092-BAD928F8-BC0C-455C-B00F-FCD9F7C8C38FQ36324332-00B90612-976C-4BC3-8167-2E86DD5AC41FQ36745194-40B1084E-2C55-44B3-A3FD-4517542C1ECBQ36828238-6830691A-55DE-45A5-AFA9-52DCCDA6B6F8Q37648544-7E40B3FA-E758-4366-9447-49A42D0E2296Q38656787-33D7543D-B0B0-4345-9FA8-2823B4383D2AQ38742179-60460732-EEEA-4824-9B38-C3C8E606330BQ40324178-5EC23454-7763-430A-81D9-CC25D7C131DDQ42109004-6022DA1C-01E0-4340-9628-F96AB4C13E86Q45967235-998EC248-B962-4FCE-8062-3942EAC49B13Q48280242-0649C9BF-AB9F-43DA-950D-BA51B608ECF0Q52086673-FB1FC766-5450-40F4-95E5-A07CB46C85FBQ54198759-D8890C24-17D9-4934-A3E5-39EB0F4768C3Q58576944-BD96199A-E8EE-44A1-842F-21399166BBF0
P2860
Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@en
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@nl
type
label
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@en
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@nl
prefLabel
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@en
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Personalized cytomic assessmen ...... profile in diabetes mellitus.
@en
P2093
Andrew Bantly
Benjamin French
Emile R Mohler
Jonni S Moore
Lifeng Zhang
Michael R Rickels
Nicholas Kurtzman
Rebecca Jonas
Wade T Rogers
P2860
P304
P356
10.1002/CYTO.B.21095
P577
2013-06-05T00:00:00Z